NYSEARCA:SYNB Putnam BioRevolution ETF (SYNB) Price, Holdings, & News $29.65 -0.45 (-1.50%) As of 01/14/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatings About Putnam BioRevolution ETF (NYSEARCA:SYNB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SYNB alerts:Sign Up Key Stats Today's Range$29.59▼$29.6550-Day Range$29.33▼$31.7052-Week Range$28.24▼$33.23Volume103 shsAverage Volume638 shsMarket Capitalization$5.19 millionAssets Under Management$5.27 millionDividend Yield0.00%Net Expense Ratio0.70%Aggregate RatingModerate Buy ETF OverviewThe Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is managed by Putnam.Read More… Putnam BioRevolution ETF ExpensesTypeSYNBTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.70%0.57%0.55%0.51%0.52%Other Expenses0.00%0.57%0.49%0.57%0.53%Total Expense0.70%0.73%0.71%0.73%0.71%Fee Waiver0.00%-0.74%-0.51%-0.66%-0.56%Net Expense0.70%0.60%0.61%0.58%0.59% Receive SYNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNB ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com SYNB ETF - Frequently Asked Questions How have SYNB shares performed this year? Putnam BioRevolution ETF's stock was trading at $29.57 at the beginning of 2025. Since then, SYNB shares have increased by 0.3% and is now trading at $29.65. View the best growth stocks for 2025 here. How do I buy shares of Putnam BioRevolution ETF? Shares of SYNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details IssuerPutnam Investments Fund NamePutnam BioRevolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SYNB Inception Date9/29/2022 Fund ManagerWilliam Rives WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings37 Fund Statistics Assets Under Management$5.27 million Average Daily Volume$0.00 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorPutnam Investment Management, LLC CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest900 shs Miscellaneous Outstanding Shares175,000Beta0.98 Creation Fee$250.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Top 10 SYNB HoldingsThermo Fisher Scientific (NYSE:TMO)Holding Weight: 6.53%Danaher (NYSE:DHR)Holding Weight: 6.19%Bio-Rad Laboratories (NYSE:BIO)Holding Weight: 5.88%NVIDIA (NASDAQ:NVDA)Holding Weight: 5.53%Corteva (NYSE:CTVA)Holding Weight: 4.94%AbbVie (NYSE:ABBV)Holding Weight: 4.62%Novonesis A/SHolding Weight: 4.45%Alphabet (NASDAQ:GOOGL)Holding Weight: 3.71%Ascendis Pharma A/S (NASDAQ:ASND)Holding Weight: 3.68%AstraZeneca (NASDAQ:AZN)Holding Weight: 3.64%Full Holdings DetailsSYNB Sector ExposureSYNB Industry Exposure This page (NYSEARCA:SYNB) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
